About papillary carcinoma true statements are all except
The question is an "all except" type, so I have to figure out which statement among the options isn't true. Let's think about possible options that might be presented. Common true statements about PTC include being the most common thyroid cancer, having a good prognosis, and being associated with certain mutations like BRAF or RET/PTC. It's also known to spread to lymph nodes, which is a common feature but doesn't necessarily affect prognosis negatively.
Now, what's a false statement? Maybe something about it being the least common type, or having a poor prognosis, or not having a specific mutation. For example, if an option says "Papillary carcinoma is the most aggressive thyroid cancer," that's false because anaplastic is the aggressive one. Alternatively, if an option states that it's radiosensitive, which is true, but maybe another option says it's resistant to radioiodine therapy, which would be incorrect because PTC is typically radioiodine-responsive.
Wait, the user hasn't provided the actual options, so I need to base this on common distractors. Let me think of typical incorrect statements. For example, an option might claim that PTC is more common in males than females, but actually, it's more common in females. Another could be that it's associated with a high mortality rate, which is not true. Or maybe an option says that it doesn't involve lymph node metastasis, but PTC often does metastasize to lymph nodes.
The core concept here is understanding the epidemiology, histology, prognosis, and treatment of papillary thyroid carcinoma. The correct answer would be the one that contradicts these facts. For instance, if an option states that papillary carcinoma is the least common type, that's incorrect because follicular is less common than papillary. Or if it says it's radiosensitive, which is true, but if another option says it's resistant, that's wrong.
Putting this all together, the false statement would be something that misrepresents a key fact about PTC. The clinical pearl here is to remember that papillary thyroid carcinoma is the most common, has a good prognosis, and is associated with specific genetic mutations. The high-yield fact is that lymph node involvement is common but doesn't portend a bad prognosis.
**Core Concept**
Papillary thyroid carcinoma (PTC) is the **most common thyroid malignancy**, characterized by **papillary architecture**, **psammoma bodies**, and **nuclear features** like nuclear grooves and inclusions. It is **associated with BRAF or RET/PTC mutations** and typically has a **favorable prognosis**, even with lymph node metastasis.
**Why the Correct Answer is Right**
The correct answer would contradict a known fact about PTC. For example, if an option claimed PTC is **radioresistant**, this is false because PTC is **radioiodine-sensitive** due to functional sodium-iodide sym